연구동향 분석

Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines

왕희령 박원명 박영민 이황빈 송후림 정종현 서정석 임은성 홍정완 김원 전덕인 홍진표 우영섭 민경준 2014년

논문상세정보
인용/피인용
' Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • algorithm
  • depressive disorder
  • kmap-dd2012.
  • pharmacotherapy
  • treatmentguideline
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
529 0

0.0%

' Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines' 의 참고문헌

  • 항우울제를 복용 중인 주요 우울증 환자에서 조기 치료 중단율과 위험 요인
    이경욱 대한정신약물학회지 17 6 550-556 [2006]
  • 한국형 우울장애 약물치료 알고리듬 2006 (Ⅰ)
    서정석 신경정신의학 46 5 453-460 [2007]
  • 주요 정신질환의 약물치료에 대한 한국형 알고리듬 개발 (1) - 알고리듬과 임상지침서의 장·단점 및 개발과 관련된 일반사항 -
    안용민 대한정신약물학회지 13 1 18-29 [2002]
  • World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care
    Bauer M World J Biol Psychiatry 8 67-104 [2007]
  • Use of atypical antipsychotics in refractory depression and anxiety
    Nemeroff CB J Clin Psychiatry 66 Suppl 8 13-21 [2005]
  • Treatment of Patients with Major Depression and Practical Guideline 3rd Edition
  • Treatment considerations for depression in the elderly
    Dunner DL CNS Spectr 8 12 Suppl 3 14-19 [2003]
  • The “NICE Guideline” on the treatment of depression
    Goldberg D Epidemiol Psichiatr Soc 15 11-15 [2006]
  • The effectiveness of olanzapine, risperidone, quetiapine, and ziprasidone as augmentation agents in treatment-resistant major depressive disorder
    Barbee JG J Clin Psychiatry 65 975-981 [2004]
  • The STAR*D study: treating depression in the real world
    Gaynes BN Cleve Clin J Med 75 57-66 [2008]
  • The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000
    Sachs GS Postgrad Med Spec 1-104 [2000]
  • Texas Medication Algorithm Project Procedural Manual Major depressive disorder algorithms
    Suehs B - [2008]
  • Texas Children’s Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder
    Hughes CW J Am Acad Child Adolesc Psychiatry 46 667-686 [2007]
  • Targeting treatment-resistant depression
    Mathys M J Pharm Pract 24 520-533 [2011]
  • Preliminary experience with adjunctive quetiapine in patients receiving selective serotonin reuptake inhibitors
    Adson DE Depress Anxiety 19 121-126 [2004]
  • Practice parameter for the assessment and treatment of children and adolescents with depressive disorders
    Birmaher B J Am Acad Child Adolesc Psychiatry 46 1503-1526 [2007]
  • New insights into perinatal depression: pathogenesis and treatment during pregnancy and postpartum
    Meltzer-Brody S Dialogues Clin Neurosci 13 89-100 [2011]
  • Low-dose risperidone augmentation of antidepressants in nonpsychotic depressive disorders with suicidal ideation
    Viner MW J Clin Psychopharmacol 23 104-106 [2003]
  • Korean Medication Guideline for Depressive Disorder 2012
  • Implications of failing to achieve successful long term maintenance treatment of recurrent unipolar major depression
    Keller MB Biol Psychiatry 44 348-360 [1998]
  • Health Services Utilization and Depression Care Quality among Depressed Patients
    Kim NS - [2008]
  • Efficacy and tolerability of adjunctive ziprasidone in treatment-resistant depression:a randomized, open-label, pilot study
    Dunner DL J Clin Psychiatry 68 1071-1077 [2007]
  • Diagnosis, pathophysiology, and management of mood disorders in pregnant and postpartum women
    Yonkers KA Obstet Gynecol 117 961-977 [2011]
  • Depression: the treatment and management of depression in adults (updated edition)
  • Definition and epidemiology of treatment-resistant depression
    Fava M Psychiatr Clin North Am 19 179-200 [1996]
  • Canadian Network for Mood and Anxiety Treatments (CANMAT)clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy
    Lam RW J Affect Disord 117 Suppl 1 S26-S43 [2009]
  • Canadian Network for Mood and Anxiety Treatments (CANMAT). Clinical guidelines for the treatment of depressive disorders
    Canadian Psychiatric Association Can J Psychiatry 46 Suppl 1 5S-90S [2001]
  • Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. Introduction
    Kennedy SH J Affect Disord 117 Suppl 1 S1-S2 [2009]
  • Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major dperessive disorder: a meta-analysis
    Papakostas GI J Clin Psychiatry 68 826-831 [2007]
  • Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder
    Papakostas GI J Clin Psychiatry 66 1326-1330 [2005]
  • Aripiprazole augmentation of selective serotonin reuptake inhibitors for treamtent-resistant major depressive disorder
    Papakostas GI J Clin Psychiatry 66 1326-1330 [2005]
  • A systematic review of antidepressant placebo-controlled trials for geriatric depression: limitations of current data and directions for the future
    Taylor WD Neuropsychopharmacology 29 2285-2299 [2004]
  • A case of morning light treatment for a depressive episode with seasonal pattern
    Joe SH J Korean Neuropsychiatr Assoc 37 585-592 [1998]